ClinicalTrials.govpublic full text
Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
type 2 diabetes, t2dm, cycloset, glycemic control, glp-1, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 852373
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.